FDA inspection
Hunan Jiudian Hongyang Pharmaceutical Co., Ltd.: FDA inspection ending May 17, 2024
FDA inspection 1242063 · No Action Indicated (NAI) · Changsha
Key facts
| Inspection ID | 1242063 |
|---|---|
| Firm | Hunan Jiudian Hongyang Pharmaceutical Co., Ltd. |
| FEI number | 3015337388 |
| Address | Wangcheng, 360 Tongguan Circular Economy Industrial Base; Economic Development Zone |
| City | Changsha |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | May 17, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data